CBD itself is not regulated in Peru, but it is the interpretation of CannIntelligence that a specific licence is required to sell hemp products.
Industrial hemp was legalised in February 2019 by a regulation that differentiates hemp from medical cannabis depending on the THC content.
A regulation on the medicinal use of cannabis was passed in February 2023.
This report offers a comprehensive overview of the current regulatory framework in place in Peru for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis.
Reasons to buy
A CannIntelligence regulatory report will provide you with:
- A clear and detailed understanding of current regulatory requirements affecting this sector in a specific jurisdiction, enabling you to be confident your business and your products are compliant.
- The ability to plan ahead for specific regulatory changes.
- Strategic understanding of the policy climate within the jurisdiction, enabling you to forecast how it might affect business development.
- Sources of further information, for example, links to full texts of legislation and contact details for relevant government offices.
Table of contents
- Executive summary
- Hemp plant
- Extracts as finished products
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
Our research is completely independent and original. It is conducted by CannIntelligence’s multilingual legal analysis team, all specialists in this sector, and goes through a rigorous review and editing process before publication. Research draws on multiple sources, including: online and offline resources and data, specialist legal software, our own extensive databases and report archives, interviews with key stakeholders and government officials, and collaboration with local legal firms and on-the-ground professionals in the jurisdictions covered.